Invest-NL
VC Fund
Amsterdam, The Netherlands
Invest-NL is a investment company.
- Total investments:
- 104
- Last investment:
- Lead investor:
- 37%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Invest-NL invests in
Stages Invest-NL invests in
Countries Invest-NL invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ruud Zandvliet
|
|||
Toen Zonneveld
|
|||
Bastiaan Gielink
|
|||
Elisabeth Storm de Grave
|
|||
Lars Groenveld
|
Investment Focus
Industry
- Manufacturing 10 (10%)
- Energy 9 (9%)
- Health Care 9 (9%)
- Medical Device 9 (9%)
- Semiconductor 7 (7%)
Stage
- Funding Round 23 (22%)
- Series A 15 (14%)
- Series B 11 (11%)
- Seed 7 (7%)
- Series C 4 (4%)
Country
- The Netherlands 51 (49%)
- United States 2 (2%)
- France 1 (1%)
- Germany 1 (1%)
- Switzerland 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ruud Zandvliet
Investment Principal
|
Investment Principal | Total investments: 2 | Find email | |
|
Toen Zonneveld
CEO
|
CEO | Total investments: 8 | Find email | |
|
Bastiaan Gielink
Senior Investment Manager
|
Senior Investment Manager | Total investments: 1 | Find email | |
|
Elisabeth Storm de Grave
Investment Principal
|
Investment Principal | Total investments: 2 | Find email | |
|
Lars Groenveld
Senior Investment Manager
|
Senior Investment Manager | Total investments: 1 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xeltis
|
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis’ restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and for coronary artery bypass graft (CABG) surgery and pulmonary heart valves, for whichclinical trials are ongoing. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs. It currently has operations in The Netherlands and in the USA. Xeltis’ investors include venture capital funds EQT Life Sciences, Kurma Partners, VI Partners and Ysios Capital as well as a number of private investors. In 2021, Xeltis secured a €15 million financing from the European Investment Bank and a €15 million funding from the European Innovation Council Accelerator (EIC) set up by the European Commission. | $23.3M / Venture - Series Unknown / Jul 28, 2026 | |
Keiron
|
Keiron provides fully digital, contactless printing technology that replaces traditional stencil and jet printing technologies. | $23.6M / Series A / Jul 21, 2026 | |
Carbeau
|
Carbeau is an independent, Avantium-spun sustainable chemistry company utilizing proprietary electrochemical technology to convert captured CO₂ into valuable building blocks. Powered by renewable energy, their focus includes sustainable glycolic acid and marine-degradable PLGA polymers. | $27.1M / Jul 07, 2026 | |
The Protein Brewery
|
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based protein in a sustainable way. It's a spin-out from BioscienZ and is commercializing innovative protein production using fermentation. It was founded by Wim de Laat in 2019 and is based in Breda, Noord-Brabant, The Netherlands. | $20.5M / Series B / Jun 29, 2026 | |
Leyden Labs
|
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains ofrespiratory viruses, including ones in the influenza and coronavirus families. The Company’s energetic team of world-renown biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. | $45.4M / Jun 25, 2026 | |
Nearfield Instruments
|
Nearfield Instruments develops and markets High-Throughput Scanning Probe Metrology systems for advanced integrated circuits manufacturing process control. | $380M / Series D / Jun 22, 2026 | |
|
Nearfield Instruments
|
Nearfield Instruments develops and markets High-Throughput Scanning Probe Metrology systems for advanced integrated circuits manufacturing process control. | $380M / Series D / Jun 22, 2026 | |
Vertoro
|
Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and fuels. | $11.5M / Series B / Jun 17, 2026 | |
Eyeo
|
Eyeo is fundamentally redefining image sensing by eliminating decades-old limitations, Capturing all incoming light and drastically improving resolution. | $47M / Series A / May 11, 2026 | |
QuantWare
|
QuantWare develops and fabricates superconducting quantum processors and related hardware for use in quantum computing systems. The company provides quantum processing units (QPUs) with different configurations, along with components such as quantum amplifiers and foundry services that support the design and production of quantum devices. Itstechnology is based on a 3D scaling architecture that aims to increase qubit counts and improve performance while addressing limitations in existing quantum hardware. QuantWare supplies its hardware to researchers, technology companies, and other organizations working on building and scaling quantum computers across multiple countries. In addition to manufacturing processors, the company supports the broader quantum ecosystem by offering commercially available hardware and infrastructure for developing large-scale quantum computing systems. | $178M / Series B / May 05, 2026 | |
| See all 104 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Invest-NL invest in?
Invest-NL invests primarily in Manufacturing, Energy and Health Care startups, most often at Funding Round and Series A stage. Most of the 104 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Invest-NL?
Public channels for Invest-NL include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Invest-NL?
The team at Invest-NL includes Ruud Zandvliet (Investment Principal), Toen Zonneveld (CEO) and Bastiaan Gielink (Senior Investment Manager), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
